In conclusion, these data suggest a crucial role for DKK1 in esophageal carcinoma as a biomarker for treatment response and poor overall survival, which should be further evaluated in prospective studies to be implemented into clinical routine. This evidence concerns the gene DKK1 and carcinoma of esophagus.